symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
BWV,0.4115,0,73393,6545196,0,0.39-1.95,-0.0055,"Blue Water Vaccines, Inc.",USD,0001782107,US06739F1350,09610B108,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.bluewatervaccines.com,"Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.","Dr. Neil J. Campbell MA, MBA",Healthcare,US,12,513 620 4101,201 East Fifth Street,Cincinnati,OH,45202,,0,https://financialmodelingprep.com/image-stock/BWV.png,2022-02-18,True,False,True,False,False
